Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 3 1

Status

Completed 8Unknown 3Recruiting 2Terminated 1Not yet recruiting 1

Sponsor Class

OTHER 2OTHER_GOV 1

Study Type

Interventional 3

Sponsor

Cancer Type

Lymphoid 2Thoracic 1

Conditions

Breast Neoplasms 33Carcinoma, Non-Small-Cell Lung 23Lung Neoplasms 11Triple Negative Breast Neoplasms 3Recurrence 3Esophageal Squamous Cell Carcinoma 3Neoplasms 2Lymphoma, Large B-Cell, Diffuse 2Lymphoma 2Hodgkin Disease 2Unspecified Adult Solid Tumor, Protocol Specific 1Thoracic Neoplasms 1Small Cell Lung Carcinoma 1Sarcoma, Ewing 1Sarcoma 1Rhabdomyosarcoma 1Respiratory Tract Neoplasms 1Respiratory Tract Diseases 1Prostatic Neoplasms 1Primary Breast Cancer 1Pathologic Residual Cancer Cells 1Ovarian Neoplasms 1Osteosarcoma 1Nonhematologic Malignancies 1Non-small Cell Lung Cancer Stage â…¡ 1Non-small Cell Lung Cancer Metastatic 1Neuroblastoma 1Neoplasms, Connective and Soft Tissue 1Neoplasm Metastasis 1NSCLC 1

Interventions

Cyclophosphamide 17fludarabine 13Dexamethasone 12Cisplatin 12Rituximab 10Gemcitabine 9Paclitaxel 8Bendamustine Hydrochloride 8Lenalidomide 7Decitabine 7Cytarabine 7Carboplatin 7fludarabine phosphate 6N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide 6Etoposide 6Bortezomib 6Radiotherapy 5Injections 5Azacitidine 5camrelizumab 4apatinib 4Valproic Acid 4Thalidomide 4Procarbazine 4Oxaliplatin 4Drug Therapy 4Bevacizumab 4Antilymphocyte Serum 4venetoclax 3pomalidomide 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Unknown × Recurrence × Vinorelbine × Clear all
NCT02733380 2020-04-01

Chidamide Combined With VDDT Regimen in the Relapse and Refractory Diffuse Large B Cell Lymphoma

Henan Cancer Hospital

Phase 2 Unknown
20 enrolled
Lymphoid

Recurrence, Lymphoma, Large B-Cell, Diffuse

NCT02281708 2014-11-03

Multicenter Randomized Controlled Trial Adjuvant Chemotherapy vs Observation in pStage Ib Lung Adenocarcinoma

Seoul National University Hospital

Phase 3 Unknown
1,012 enrolled
Thoracic

Lung Neoplasms, Recurrence

NCT01884441 2014-01-29

Bendamustine, Gemcitabine and Vinorelbine (BeGEV) as Induction Therapy in Relapsed/Refractory Hodgkin's Lymphoma Patients

Istituto Clinico Humanitas

Phase 2 Unknown
59 enrolled
Lymphoid

Hodgkin Disease, Lymphoma, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡